Strata Skin Sciences Stock Performance
| SSKN Stock | USD 0.35 0.04 10.26% |
The entity has a beta of 3.89, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, STRATA Skin will likely underperform. At this point, STRATA Skin Sciences has a negative expected return of -1.4%. Please make sure to validate STRATA Skin's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if STRATA Skin Sciences performance from the past will be repeated at some future point.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days STRATA Skin Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward-looking signals remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:10 | Dividend Date 2017-04-07 | Last Split Date 2024-06-07 |
1 | Acquisition by Rubinstein Samuel of 2168 shares of STRATA Skin at 1.4 subject to Rule 16b-3 | 11/18/2025 |
2 | STRATA Skin Sciences Showcases XTRAC and TheraclearX at TeraCILAD 2025 Reports Early Adoption Momentum in Mexico | 12/09/2025 |
3 | Strata Skin Sciences Outlines Growth Initiatives for 2025 - TipRanks | 12/17/2025 |
4 | Acquisition by Rubinstein Samuel of 2832 shares of STRATA Skin at 1.41 subject to Rule 16b-3 | 02/05/2026 |
5 | STRATA Skin Sciences Received Notice of Delisting - TradingView | 02/11/2026 |
6 | Acquisition by Robert Moccia of 33300 shares of STRATA Skin at 1.5735 subject to Rule 16b-3 | 02/13/2026 |
| Begin Period Cash Flow | 8.1 M | |
| Total Cashflows From Investing Activities | -1.6 M |
STRATA Skin Relative Risk vs. Return Landscape
If you would invest 135.00 in STRATA Skin Sciences on November 19, 2025 and sell it today you would lose (100.00) from holding STRATA Skin Sciences or give up 74.07% of portfolio value over 90 days. STRATA Skin Sciences is currently does not generate positive expected returns and assumes 9.7608% risk (volatility on return distribution) over the 90 days horizon. In different words, 87% of stocks are less volatile than STRATA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
STRATA Skin Target Price Odds to finish over Current Price
The tendency of STRATA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.35 | 90 days | 0.35 | close to 99 |
Based on a normal probability distribution, the odds of STRATA Skin to move above the current price in 90 days from now is close to 99 (This STRATA Skin Sciences probability density function shows the probability of STRATA Stock to fall within a particular range of prices over 90 days) .
STRATA Skin Price Density |
| Price |
Predictive Modules for STRATA Skin
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as STRATA Skin Sciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.STRATA Skin Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. STRATA Skin is not an exception. The market had few large corrections towards the STRATA Skin's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold STRATA Skin Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of STRATA Skin within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.84 | |
β | Beta against Dow Jones | 3.89 | |
σ | Overall volatility | 0.21 | |
Ir | Information ratio | -0.18 |
STRATA Skin Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of STRATA Skin for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for STRATA Skin Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| STRATA Skin Sciences generated a negative expected return over the last 90 days | |
| STRATA Skin Sciences has high historical volatility and very poor performance | |
| STRATA Skin Sciences has some characteristics of a very speculative penny stock | |
| STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 33.56 M. Net Loss for the year was (10.09 M) with profit before overhead, payroll, taxes, and interest of 17.89 M. | |
| Latest headline from news.google.com: STRATA Skin Sciences Received Notice of Delisting - TradingView |
STRATA Skin Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of STRATA Stock often depends not only on the future outlook of the current and potential STRATA Skin's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. STRATA Skin's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.1 M | |
| Cash And Short Term Investments | 7.3 M |
STRATA Skin Fundamentals Growth
STRATA Stock prices reflect investors' perceptions of the future prospects and financial health of STRATA Skin, and STRATA Skin fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on STRATA Stock performance.
| Return On Equity | -2.04 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.35) % | ||||
| Operating Margin | (0.27) % | ||||
| Current Valuation | 11.2 M | ||||
| Shares Outstanding | 5.68 M | ||||
| Price To Earning | (0.49) X | ||||
| Price To Book | 1.49 X | ||||
| Price To Sales | 0.06 X | ||||
| Revenue | 33.56 M | ||||
| Gross Profit | 17.89 M | ||||
| EBITDA | (2.84 M) | ||||
| Net Income | (10.09 M) | ||||
| Cash And Equivalents | 10.04 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 16.44 M | ||||
| Debt To Equity | 0.35 % | ||||
| Current Ratio | 1.30 X | ||||
| Book Value Per Share | 0.25 X | ||||
| Cash Flow From Operations | 188 K | ||||
| Earnings Per Share | (2.63) X | ||||
| Market Capitalization | 1.96 M | ||||
| Total Asset | 36.16 M | ||||
| Retained Earnings | (248.14 M) | ||||
| Working Capital | 1.97 M | ||||
| Current Asset | 9.39 M | ||||
| Current Liabilities | 4.62 M | ||||
About STRATA Skin Performance
By examining STRATA Skin's fundamental ratios, stakeholders can obtain critical insights into STRATA Skin's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that STRATA Skin is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 65.10 | 61.85 | |
| Return On Tangible Assets | (0.32) | (0.34) | |
| Return On Capital Employed | (0.49) | (0.52) | |
| Return On Assets | (0.25) | (0.26) | |
| Return On Equity | (2.33) | (2.22) |
Things to note about STRATA Skin Sciences performance evaluation
Checking the ongoing alerts about STRATA Skin for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for STRATA Skin Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| STRATA Skin Sciences generated a negative expected return over the last 90 days | |
| STRATA Skin Sciences has high historical volatility and very poor performance | |
| STRATA Skin Sciences has some characteristics of a very speculative penny stock | |
| STRATA Skin Sciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 33.56 M. Net Loss for the year was (10.09 M) with profit before overhead, payroll, taxes, and interest of 17.89 M. | |
| Latest headline from news.google.com: STRATA Skin Sciences Received Notice of Delisting - TradingView |
- Analyzing STRATA Skin's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether STRATA Skin's stock is overvalued or undervalued compared to its peers.
- Examining STRATA Skin's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating STRATA Skin's management team can have a significant impact on its success or failure. Reviewing the track record and experience of STRATA Skin's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of STRATA Skin's stock. These opinions can provide insight into STRATA Skin's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRATA Skin Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Will Health Care Equipment & Supplies sector continue expanding? Could STRATA diversify its offerings? Factors like these will boost the valuation of STRATA Skin. If investors know STRATA will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every STRATA Skin data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (2.63) | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets | Return On Equity |
Investors evaluate STRATA Skin Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating STRATA Skin's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause STRATA Skin's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between STRATA Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if STRATA Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, STRATA Skin's market price signifies the transaction level at which participants voluntarily complete trades.